OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Mitochondria-Targeting Agent MitoQ Improves Muscle Atrophy, Weakness and Oxidative Metabolism in C26 Tumor-Bearing Mice
Fabrizio Pin, Joshua R. Huot, Andrea Bonetto
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Cancer-associated cachexia — understanding the tumour macroenvironment and microenvironment to improve management
Josep M. Argilés, Francisco J. López‐Soriano, Britta Stemmler, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 4, pp. 250-264
Closed Access | Times Cited: 117

Mitochondrial dysfunction: roles in skeletal muscle atrophy
Xin Chen, Yanan Ji, Ruiqi Liu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 114

Mitochondrial dysfunction and skeletal muscle atrophy: Causes, mechanisms, and treatment strategies
Gökhan Burçin Kubat, Esmaa Bouhamida, Öner Ülger, et al.
Mitochondrion (2023) Vol. 72, pp. 33-58
Closed Access | Times Cited: 53

Emerging Therapeutic Strategies in Sarcopenia: An Updated Review on Pathogenesis and Treatment Advances
Alfred Najm, Adelina-Gabriela Niculescu, Alexandru Mihai Grumezescu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4300-4300
Open Access | Times Cited: 15

Mitochondrial involvement in sarcopenia
Charles Affourtit, Jane E. Carré
Acta Physiologica (2024) Vol. 240, Iss. 3
Open Access | Times Cited: 10

Emerging Targets and Treatments for Sarcopenia: A Narrative Review
Stefano Cacciatore, Riccardo Calvani, Ilaria Esposito, et al.
Nutrients (2024) Vol. 16, Iss. 19, pp. 3271-3271
Open Access | Times Cited: 8

Nutritional Strategies for Muscle Atrophy: Current Evidence and Underlying Mechanisms
Yuntian Shen, Chen Zhang, Chaolun Dai, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 10
Closed Access | Times Cited: 7

Nanodrug Delivery Systems for Myasthenia Gravis: Advances and Perspectives
Jiayan Huang, Yan Zhao, Yafang Song, et al.
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 651-651
Open Access | Times Cited: 6

Reactive oxygen species in skeletal muscle injury, fatigue, regeneration and ageing: In memory of John Faulkner
Hongyang Xu, Jacob L. Brown, Shylesh Bhaskaran, et al.
Free Radical Biology and Medicine (2024)
Open Access | Times Cited: 5

PGC1α overexpression preserves muscle mass and function in cisplatin‐induced cachexia
Joshua R. Huot, Fabrizio Pin, R Chatterjee, et al.
Journal of Cachexia Sarcopenia and Muscle (2022) Vol. 13, Iss. 5, pp. 2480-2491
Open Access | Times Cited: 18

Muscle Delivery of Mitochondria-Targeted Drugs for the Treatment of Sarcopenia: Rationale and Perspectives
Francesco Bellanti, Aurelio Lo Buglio, Gianluigi Vendemiale
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2588-2588
Open Access | Times Cited: 17

Unacylated Ghrelin Counteracts Contractile and Mitochondrial Dysfunction in Cancer Cachexia
Bumsoo Ahn, Jonathan Wanagat, Caroline Cleary, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access

Perspectives on the interpretation of mitochondrial responses during skeletal muscle disuse‐induced atrophy
Luca J. Delfinis, Shahrzad Khajehzadehshoushtar, Christopher G. R. Perry
The Journal of Physiology (2025)
Open Access

Prognostic value of the Glucose-to-Albumin ratio in sepsis-related mortality: A retrospective ICU study
Y L Ge, Zhe Wang, Yanlin Ma, et al.
Diabetes Research and Clinical Practice (2025) Vol. 224, pp. 112217-112217
Closed Access

Erlotinib combination with a mitochondria-targeted ubiquinone effectively suppresses pancreatic cancer cell survival
P. Y. Leung, Wenjing Chen, Anissa N Sari, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 7, pp. 714-727
Open Access | Times Cited: 3

Anticancer Effects of Mitoquinone via Cell Cycle Arrest and Apoptosis in Canine Mammary Gland Tumor Cells
Ran Lee, Won-Young Lee, Hyun-Jung Park
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4923-4923
Open Access | Times Cited: 3

Targeting Mitochondria and Oxidative Stress in Cancer- and Chemotherapy-Induced Muscle Wasting
Joshua R. Huot, Dryden R. Baumfalk, Aridai Resendiz, et al.
Antioxidants and Redox Signaling (2022)
Open Access | Times Cited: 13

Selpercatinib combination with the mitochondria-targeted antioxidant MitoQ effectively suppresses RET–mutant thyroid cancer
Wenjing Chen, Sophie Dream, P. Y. Leung, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 2

Long-term Musculoskeletal Consequences of Chemotherapy in Pediatric Mice
Joshua R. Huot, Patrick D. Livingston, Fabrizio Pin, et al.
Function (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 2

Age Is Just a Number: Progress and Obstacles in the Discovery of New Candidate Drugs for Sarcopenia
Hyun-Jun Kim, Da‐Woon Jung, Darren R. Williams
Cells (2023) Vol. 12, Iss. 22, pp. 2608-2608
Open Access | Times Cited: 4

Mitochondria-Targeted Antioxidant MitoQ Improves In Vitro Maturation and Subsequent Embryonic Development from Culled Cows
Zhihao Feng, Junsong Shi, Jiaxue Ren, et al.
Animals (2024) Vol. 14, Iss. 20, pp. 2929-2929
Open Access | Times Cited: 1

Reactive oxygen species in age-related musculoskeletal decline: implications for nutritional intervention
Malcolm J. Jackson
Proceedings of The Nutrition Society (2024), pp. 1-9
Open Access | Times Cited: 1

Pharmacotherapeutic options for cancer cachexia: emerging drugs and recent approvals
Lorena Garcia‐Castillo, Giacomo Rubini, Paola Costelli
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 9, pp. 1053-1065
Closed Access | Times Cited: 3

Cancer cachexia – adopting a systems wide approach
Judith Sayers, Richard J. E. Skipworth, Barry Laird
Current Opinion in Clinical Nutrition & Metabolic Care (2023) Vol. 26, Iss. 4, pp. 393-398
Closed Access | Times Cited: 3

Page 1 - Next Page

Scroll to top